Skip to nav Skip to content

Moffitt Cancer Center’s Genitourinary Oncology Program consists of a multidisciplinary team that is at the forefront of research and treatment of urologic cancers, such as bladder, kidney, prostate, testis and penile cancer. As a referring physician, your patients will have access to the full spectrum of specialized care at Moffitt. Our services include:


Evidence-driven treatment options

Moffitt offers a diverse range of treatments to patients with all types of urologic cancers. These include:

  • Active surveillance for prostate conditions
  • Chemoprevention
  • Chemotherapy
    • Molecular targeted therapeutics
    • Neoadjuvant chemotherapy protocols
  • Immunotherapy
  • Innovative therapies
    • Gene therapies
    • Hormone therapies
    • Vaccine therapies
  • Radiation therapy
    • Interventional Radiology
      • Prostatic Artery Embolization
    • Conformal radiotherapy
    • HDR brachytherapy (seeds)
    • Stereotactic radiosurgery (SRS)
    • Stereotactic body radiotherapy (SBRT)
      • MR-guided radiotherapy
      • CT-guided radiotherapy
    • Intensity modulated radiation therapy (IMRT)
  • Surgery
    • Inguinal, pelvic and retroperitoneal lymph node dissection
    • Minimally invasive surgical approaches
      • Laser surgery
      • Cryoablation and radiofrequency ablation (RFA)
      • Laparoscopic and robotic surgery
    • da Vinci® robotic surgery for cancers of the bladder, kidney, testis, adrenal and prostate
    • Partial and radical nephrectomy
    • Prostatectomy (nerve-sparing techniques)
    • Partial and radical orchiectomy
    • Partial and total penectomy
    • Radical cystectomy and various forms of urinary diversion (orthotopic, continent cutaneous, ileal conduit)
    • Organ- and sexual function-preserving surgical approaches
    • Retroperitoneal lymph node dissection (RPLND)
    • Inguinal lymph node dissection (ILND)
  • Clinical trials

Refer a patient 

Referring a patient to Moffitt’s Genitourinary Oncology Program is simple—contact a physician liaison for assistance or submit an online form. We understand that a timely response is critical when it comes to cancer treatment, which is why our team strives to answer all referral requests within 24-48 hours.